Author: News Room
Dublin, March 07, 2025 (GLOBE NEWSWIRE) — The “Microneedles for Drug Delivery Patent Landscape Report and Forecast 2024-2032” report has been added to ResearchAndMarkets.com’s offering. The microneedles drug delivery system represents a transformative advancement in the pharmaceutical industry, offering a minimally invasive solution for administering medications. This innovative technology ensures painless penetration of the skin’s outer barrier, delivering drugs directly into dermal layers. As chronic ailments become more prevalent and the demand for patient-friendly drug delivery methods increases, the significance of microneedles in the global healthcare market is becoming increasingly recognized. Advancements and Key Market DriversNew research highlights the rapid…
Dublin, March 07, 2025 (GLOBE NEWSWIRE) — The “Zollinger Ellison Syndrome Market” report has been added to ResearchAndMarkets.com’s offering.The Zollinger Ellison Syndrome market was valued at USD 1.34 billion in 2024 driven by innovations in treatment options across the 8 major markets. It is expected to grow at a CAGR of 4.40% during the forecast period of 2025-2034 and attain a market value of USD 2.07 billion by 2034. The Zollinger Ellison syndrome market features key players such as Novartis AG, GSK Plc, Bayer AG, Pfizer Inc., and Bristol Myers Squibb Company, which are leading the development of proton pump…
Dublin, March 07, 2025 (GLOBE NEWSWIRE) — The “Contraceptive Devices Patent Landscape Report” report has been added to ResearchAndMarkets.com’s offering.The global contraceptive devices market, valued at USD 24.45 billion in 2023, is projected to grow at a CAGR of 6.4% to reach USD 42.7 billion by 2032. The growth is driven by patent innovations in materials, smart monitoring, and eco-friendly contraceptive methods, enhancing comfort, safety, and efficacy in personalized reproductive solutions. This comprehensive report explores the global patent landscape for contraceptive devices, offering a detailed analysis of patent filings, technological advancements, and regional contributions. It covers key segments by product…
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $50,000 In Newmont To Contact Him Directly To Discuss Their Options If you suffered losses exceeding $50,000 in Newmont between February 22, 2024 and October 23, 2024 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310). [You may also click here for additional information] NEW YORK, March 07, 2025 (GLOBE NEWSWIRE) — Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Newmont Corporation (“Newmont” or…
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $50,000 In ModivCare To Contact Him Directly To Discuss Their Options If you suffered losses exceeding $50,000 in ModivCare between November 3, 2022 and May 3, 2023 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310). [You may also click here for additional information] NEW YORK, March 07, 2025 (GLOBE NEWSWIRE) — Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against ModivCare, Inc. (“ModivCare” or…
COLLEGEVILLE, Pa., March 07, 2025 (GLOBE NEWSWIRE) — Toll Brothers, Inc. (NYSE:TOL), the nation’s leading builder of luxury homes, today announced that Charterfield Landing is now open for sale in Collegeville, Pennsylvania. This new community showcases an exclusive selection of expansive home sites with thoughtfully designed open-concept floor plans featuring side-entry garages and basements, as well as sophisticated options for personalization. The Sales Center and model home are now open at 4037 MacCormack Way in Collegeville. “Charterfield Landing provides home buyers with the opportunity to experience luxury living in a peaceful and picturesque setting,” said John Dean, Division President of…
TORONTO, March 07, 2025 (GLOBE NEWSWIRE) — ESET, a global leader in cybersecurity, today announced the anniversary of its Women in Cybersecurity North American Scholarship, launched in 2016 to support and empower women pursuing careers in cybersecurity. As part of its ongoing commitment to fostering diverse talent, ESET is expanding the program in Canada, increasing both the number and value of scholarships available to Canadian applicants. For a decade, ESET North America has encouraged and uplifted women to pursue careers in cybersecurity, offering financial assistance to help achieve their aspirations. In solidarity with the 2025 International Women’s Day’s #AccelerateAction theme,…
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $75,000 In BioAge To Contact Him Directly To Discuss Their Options If you suffered losses exceeding $75,000 in BioAge between September 26, 2024 and January 7, 2025 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310). [You may also click here for additional information] NEW YORK, March 07, 2025 (GLOBE NEWSWIRE) — Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against BioAge Labs, Inc. (“BioAge”…
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $100,000 In Regeneron To Contact Him Directly To Discuss Their Options If you suffered losses exceeding $100,000 in Regeneron between November 2, 2023 and October 30, 2024 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310) [You may also click here for additional information] NEW YORK, March 07, 2025 (GLOBE NEWSWIRE) — Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Regeneron Pharmaceuticals, Inc. (“Regeneron”…
BOERNE, Texas, March 07, 2025 (GLOBE NEWSWIRE) — Toll Brothers, Inc. (NYSE:TOL), the nation’s leading builder of luxury homes, announced the opening of the highly anticipated community clubhouse and onsite amenities at Regency at Esperanza, a premier 55+ active-adult community in Boerne, Texas. The grand opening event will be held at the community, located at 130 Navarro in Boerne, on Saturday, March 15th from noon to 4 pm CT. Existing and prospective home buyers are invited to attend the event featuring live music by Royal Dukes and an assortment of light fare and refreshments. The new Toll Brothers community clubhouse, The Hacienda,…